Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-1-21
|
pubmed:abstractText |
In order to cast light on the possible role of bcl-2 protein (Bcl-2) expression in gastric tumorigenesis, 33 cases of gastric adenomas and carcinomas originating from the same stomachs were immunohistochemically investigated for Bcl-2 protein (Bcl-2) expression, accumulation of p53 protein and cell proliferation as determined by the Ki-67 labeling index (LI). Bcl-2 expression was detected in 24/33 (72.7%) adenomas and in 6/33 (18.2%) carcinomas, the difference being statistically significant (P = 0.0001). Only 4 of 33 (12.1%) cases exhibited expression in both adenoma and carcinoma lesions in the same stomachs. Immunoreactivity was decreased in areas of cellular and structural atypia in adenoma lesions (P < 0.008), and appeared to be positively linked to the tumor progression and the degree of differentation in carcinomas, although it did not reach statistical significance. Accumulation of p53 protein was rare in the adenomas but was found in 15/33 (45.5%) of carcinoma lesions, with a significant dissociation from Bcl-2 immunoreactivity. No apparent relation between Ki-67 LI and either adenoma grading or carcinoma typing was noted, although average Ki-67 LI of the highest labeling areas in carcinomas was statistically higher than in adenomas (P = 0.0001). These results indicate that the regulation of Bcl-2 expression may differ between gastric adenomas and carcinomas, may be correlated with tumor differentiative features. In addition, p53 accumulation may play an important role in the onset of malignancy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1320-5463
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
274-80
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:8726851-Adenoma,
pubmed-meshheading:8726851-Carcinoma,
pubmed-meshheading:8726851-Humans,
pubmed-meshheading:8726851-Immunohistochemistry,
pubmed-meshheading:8726851-Ki-67 Antigen,
pubmed-meshheading:8726851-Metaplasia,
pubmed-meshheading:8726851-Mitotic Index,
pubmed-meshheading:8726851-Protein-Tyrosine Kinases,
pubmed-meshheading:8726851-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:8726851-Stomach Neoplasms,
pubmed-meshheading:8726851-Tumor Suppressor Protein p53
|
pubmed:year |
1996
|
pubmed:articleTitle |
Different expression of Bcl-2 protein in gastric adenomas and carcinomas.
|
pubmed:affiliation |
Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|